Bleeding diathesis: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
Line 11: | Line 11: | ||
{| class="wikitable" | {| class="wikitable" | ||
|+ | |+ | ||
! | ! rowspan="2" |Category | ||
! | ! rowspan="2" |Sub-category | ||
! | ! rowspan="2" |Diseases | ||
! | ! rowspan="2" | | ||
! rowspan="2" |History | ! rowspan="2" |History | ||
! colspan="5" |Clinical manifestation | ! colspan="5" |Clinical manifestation | ||
! colspan="5" |Laboratory testing | ! colspan="5" |Laboratory testing | ||
|- | |- | ||
!'''Petechiae''' | !'''Petechiae''' | ||
!'''Ecchymoses''' | !'''Ecchymoses''' | ||
Line 36: | Line 32: | ||
| rowspan="15" |Platelet disorders | | rowspan="15" |Platelet disorders | ||
| rowspan="7" |'''Thrombocytopenia''' | | rowspan="7" |'''Thrombocytopenia''' | ||
|Infection-Induced Thrombocytopenia<span name="harr_c115s002s001s002p001"></span><span name="9100754"></span> | |[[Infection]]-Induced Thrombocytopenia<span name="harr_c115s002s001s002p001"></span><span name="9100754"></span> | ||
| | | | ||
| | | | ||
Line 50: | Line 46: | ||
| | | | ||
|- | |- | ||
| | |[[Medication|Medications]]-Induced Thrombocy<span name="harr_c115s002s001s003p001"></span><span name="9100757"></span>topenia | ||
| | | | ||
| | | | ||
Line 64: | Line 60: | ||
| | | | ||
|- | |- | ||
|Heparin-Induced Thrombocytopenia<span name="harr_c115s002s001s004p001"></span><span name="9100761"></span> | |[[Heparin]]-Induced Thrombocytopenia<span name="harr_c115s002s001s004p001"></span><span name="9100761"></span> | ||
| | | | ||
| | | | ||
Line 78: | Line 74: | ||
| | | | ||
|- | |- | ||
|Immune Thrombocytopenic Purpura (ITP)<span name="harr_c115s002s001s005p001"></span><span name="9100771"></span> | |[[Idiopathic thrombocytopenic purpura|Immune Thrombocytopenic Purpura]] ([[Idiopathic thrombocytopenic purpura|ITP]])<span name="harr_c115s002s001s005p001"></span><span name="9100771"></span> | ||
| | | | ||
| | | | ||
Line 106: | Line 102: | ||
| | | | ||
|- | |- | ||
|Thrombotic Thrombocytopenic Purpura (TTP)<span name="harr_c115s002s002s001p001"></span><span name="9100787"></span> | |[[Thrombotic thrombocytopenic purpura|Thrombotic Thrombocytopenic Purpura]] ([[Thrombotic thrombocytopenic purpura|TTP]])<span name="harr_c115s002s002s001p001"></span><span name="9100787"></span> | ||
| | | | ||
| | | | ||
Line 120: | Line 116: | ||
| | | | ||
|- | |- | ||
|Hemolytic Uremic Syndrome<span name="harr_c115s002s002s002p001"></span><span name="9100796"></span> | |[[Hemolytic-uremic syndrome|Hemolytic Uremic Syndrome]]<span name="harr_c115s002s002s002p001"></span><span name="9100796"></span> | ||
| | | | ||
| | | | ||
Line 149: | Line 145: | ||
| | | | ||
|- | |- | ||
| rowspan="7" |Qualitative Disorders of Platelet Function<span name="harr_c115s002s004s001p001"></span><span name="9100803"></span> | | rowspan="7" |Qualitative Disorders of [[Platelet]] Function<span name="harr_c115s002s004s001p001"></span><span name="9100803"></span> | ||
|Inherited Disorders of Platelet Function<span name="harr_c115s002s004s001p001"></span><span name="9100803"></span> | |Inherited Disorders of [[Platelet]] Function<span name="harr_c115s002s004s001p001"></span><span name="9100803"></span> | ||
| | | | ||
| | | | ||
Line 164: | Line 160: | ||
| | | | ||
|- | |- | ||
|Acquired Disorders of Platelet Function<span name="harr_c115s002s004s002p001"></span><span name="9100808"></span> | |Acquired Disorders of [[Platelet]] Function<span name="harr_c115s002s004s002p001"></span><span name="9100808"></span> | ||
| | | | ||
| | | | ||
Line 178: | Line 174: | ||
| | | | ||
|- | |- | ||
| rowspan="5" | | | rowspan="5" |[[Von Willebrand disease|Von Willebrand Disease]]<span name="harr_c115s002s005p001"></span><span name="9100810"></span> | ||
|Type 1 | |Type 1 | ||
| | | | ||
Line 291: | Line 287: | ||
| | | | ||
|- | |- | ||
|Prothrombin deficiency | |[[Prothrombin deficiency]] | ||
| | | | ||
| | | | ||
Line 306: | Line 302: | ||
| | | | ||
|- | |- | ||
| rowspan="1" |Factor V deficiency | | rowspan="1" |[[Factor V deficiency]] | ||
| | | | ||
| | | | ||
Line 321: | Line 317: | ||
| | | | ||
|- | |- | ||
| rowspan="1" |Factor VII deficiency | | rowspan="1" |[[Factor VII deficiency]] | ||
| | | | ||
| | | | ||
Line 336: | Line 332: | ||
| | | | ||
|- | |- | ||
| rowspan="1" |Factor VIII deficiency | | rowspan="1" |[[Factor VIII deficiency]] | ||
| | | | ||
| | | | ||
Line 366: | Line 362: | ||
| | | | ||
|- | |- | ||
| rowspan="1" |Factor X deficiency | | rowspan="1" |[[Factor X deficiency]] | ||
| | | | ||
| | | | ||
Line 381: | Line 377: | ||
| | | | ||
|- | |- | ||
| rowspan="1" |Factor XI deficiency | | rowspan="1" |[[Factor XI|Factor XI deficiency]] | ||
| | | | ||
| | | | ||
Line 396: | Line 392: | ||
| | | | ||
|- | |- | ||
| rowspan="1" |Factor XII deficiency | | rowspan="1" |[[Factor XII|Factor XII deficiency]] | ||
| | | | ||
| | | | ||
Line 426: | Line 422: | ||
| | | | ||
|- | |- | ||
| rowspan="1" |Prekallikrein deficiency | | rowspan="1" |[[Prekallikrein]] deficiency | ||
| | | | ||
| | | | ||
Line 441: | Line 437: | ||
| | | | ||
|- | |- | ||
| rowspan="1" |Factor XIII deficiency | | rowspan="1" |[[Factor XIII deficiency]] | ||
| | | | ||
| | | | ||
Line 503: | Line 499: | ||
|- | |- | ||
| rowspan="4" |Rare diseases | | rowspan="4" |Rare diseases | ||
|Disseminated Intravascular Coagulation | |[[Disseminated intravascular coagulation|Disseminated Intravascular Coagulation]] | ||
| | | | ||
| | | | ||
Line 518: | Line 514: | ||
| | | | ||
|- | |- | ||
|Vitamin K Deficiency | |[[Vitamin K Deficiency]] | ||
| | | | ||
| | | | ||
Line 533: | Line 529: | ||
| | | | ||
|- | |- | ||
|Coagulation Disorders Associated with Liver Failure | |Coagulation Disorders Associated with [[Hepatic failure|Liver Failure]] | ||
| | | | ||
| | | |
Revision as of 16:47, 22 August 2018
Bleeding diathesis main page |
|
---|
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Mehrian Jafarizade, M.D [2]
Overview
Classification
Differential Diagnosis
Category | Sub-category | Diseases | History | Clinical manifestation | Laboratory testing | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Petechiae | Ecchymoses | Menorrhagia | Hematomas | Hemarthrosis | platelet count | Bleeding time (BT) | Prothrombin time (PT) | Platelet count activated partial thromboplastin time (aPTT) | Thrombin time (TT) | |||||
Platelet disorders | Thrombocytopenia | Infection-Induced Thrombocytopenia | ||||||||||||
Medications-Induced Thrombocytopenia | ||||||||||||||
Heparin-Induced Thrombocytopenia | ||||||||||||||
Immune Thrombocytopenic Purpura (ITP) | ||||||||||||||
Inherited Thrombocytopenia | ||||||||||||||
Thrombotic Thrombocytopenic Purpura (TTP) | ||||||||||||||
Hemolytic Uremic Syndrome | ||||||||||||||
Thromobcytosis | Thrombocytosis in response to acute or chronic inflammation has not been associated with an increased thrombotic risk. In fact, patients with markedly elevated platelet counts (>1.5 million), usually seen in the setting of a myeloproliferative disorder, have an increased risk of bleeding. This appears to be due, at least in part, to acquired von Willebrand disease (VWD) due to platelet-VWF adhesion and removal. | |||||||||||||
Qualitative Disorders of Platelet Function | Inherited Disorders of Platelet Function | |||||||||||||
Acquired Disorders of Platelet Function | ||||||||||||||
Von Willebrand Disease | Type 1 | |||||||||||||
Type 2 A | ||||||||||||||
Type 2 B | ||||||||||||||
Type 2 M | ||||||||||||||
Type 3 | ||||||||||||||
Vessel wall disorders | Metabolic and Inflammatory Disorders | |||||||||||||
Inherited Disorders of the Vessel Wall | ||||||||||||||
Coagulation disorders | Fibrinogen deficiency | |||||||||||||
Prothrombin deficiency | ||||||||||||||
Factor V deficiency | ||||||||||||||
Factor VII deficiency | ||||||||||||||
Factor VIII deficiency | ||||||||||||||
Factor IX deficiency | ||||||||||||||
Factor X deficiency | ||||||||||||||
Factor XI deficiency | ||||||||||||||
Factor XII deficiency | ||||||||||||||
HK deficiency | ||||||||||||||
Prekallikrein deficiency | ||||||||||||||
Factor XIII deficiency | ||||||||||||||
Hemophilia | Type A deficiency | |||||||||||||
Type B deficiency | ||||||||||||||
Type C deficiency | ||||||||||||||
Rare diseases | Disseminated Intravascular Coagulation | |||||||||||||
Vitamin K Deficiency | ||||||||||||||
Coagulation Disorders Associated with Liver Failure | ||||||||||||||
Acquired Inhibitors of Coagulation Factors |